Shared-decision making for tailored CCC disease management, crossing care paths towards daily life, and early proper treatment to prevent CCC disease progression. Identify individual multi-morbid CCC exacerbations and develop tailored referral to a multidisciplinary, adaptive virtual companionship program for COPD patients with CCCs. The RWD from daily life measurements and existing medical knowledge-base will be integrated based on inclusive models representing e.g. patients, healthcare (providers), scientists, policymakers, and industry. The RE-SAMPLE framework will be developed for privacy-securing data management and AI prediction modeling to tailor local personalised treatment programs using accurate predictions of multi-morbid exacerbations and personalised interventions.
Innovation Sprint will be providing RE-SAMPLE with the Real-World Data collection and management mechanisms and the applications for patient engagement (addressed to the patients) and for professional management (addressed to the healthcare professionals). For the applications, we will also implement and test the real-time predictions of the RE-SAMPLE trained models applied on new data. Finally, we are leading the innovation management, exploitation, and business planning activities of RE-SAMPLE.